Travere Therapeutics (TVTX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 19, 2026, at 9:00 a.m. Pacific Daylight Time in San Diego, CA.

• Proxy materials and annual report are available online, with options to request paper or email copies.

• Voting can be conducted online, by email, telephone, or in person at the meeting.

Voting matters and shareholder proposals

• Election of ten directors for a one-year term is proposed.

• Approval sought to amend the 2018 Equity Incentive Plan, increasing authorized shares by 3,000,000.

• Advisory vote on executive compensation and on the preferred frequency of such votes.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Board recommends voting for all proposals and a one-year frequency for say-on-pay votes.

Board of directors and corporate governance

• Ten nominees listed for election to the board, including Roy Baynes, Suzanne Bruhn, Timothy Coughlin, Eric Dube, Gary Lyons, Jeffrey Meckler, John Orwin, Sandra Poole, Ron Squarer, and Ruth Williams-Brinkley.